Sounds like a job for a biologist. Or maybe not. The person who cracks this mutation mystery might just be a Johns Hopkins engineer who works with cell membranes.
Kalina Hristova, an associate professor of materials science and engineering, has spent more than five years in a nontraditional effort to understand how that tiny DNA error leads to dwarfism. Hristova, an expert in the field of membrane biophysics, has focused her research on the thin protective covering that surrounds human cells, the plasma membrane; for this project, she is studying the activity of proteins that reside in this membrane. Among these proteins is the one linked to dwarfism.
A biologist might attack this puzzle by growing cells in a dish or conducting experiments with lab animals. Hristova, supported by a federal stimulus grant, instead has been using engineering tactics to determine how the protein may be wreaking havoc. Her lab has developed new tools and techniques that allow her to take pictures and make measurements that reveal how the rogue protein is behaving in the cell membrane. Her team’s goal is to generate exact numbers that will yield clues about how the protein causes the cells to take a wrong turn.
“Unlike the biologists, we are not investigating what will happen to the cell in 20 days,” she said. “We are looking at the initial events occurring in the cell membrane, the way proteins first interact there. As engineers, we have to strip down the system and simplify it so that we can see how it works. We are looking at the physics, not the biology.”
For her project, called “Seeking the Physical Basis of Achondroplasia,” Hristova has received a $27,000 federal stimulus grant for lab equipment, which supplements her five-year grant of approximately $1 million from the National Institutes of Health. Her award is among the 424 stimulus-funded research grants and supplements totaling more than $200 million that Johns Hopkins has garnered since Congress passed the American Recovery and Reinvestment Act of 2009, bestowing the NIH and the National Science Foundation with $12.4 billion in extra money to underwrite research grants by September 2010.
Achondroplasia, the focus of Hristova’s grant, is the most common form of short-limbed dwarfism, occurring in one in 15,000 to 40,000 newborns worldwide, according to the National Institutes of Health. The condition results from a mutated FGFR3 gene. In some cases, this mutation is passed down by at least one parent. But about 80 percent of those with achondroplasia have average-size parents and develop the condition because a new mutation occurs. This defective gene produces proteins that send “stop” signals, halting the growth of cartilage that makes room for normal-size long bones of the arms and legs.
Hristova cautions that no “cure” for achondroplasia exists and that her research is unlikely to produce one in the near future. She describes her work as basic research that could lay the groundwork for future treatment or prevention of achondroplasia.
“Finding the cause of this condition is a very hard problem, because the first thing you need to do is to understand what’s happening at the molecular level, what these proteins are actually doing,” she said. “Before you can solve a problem, you need to know what’s causing it.”
The proteins Hristova is examining are tiny threads of amino acids embedded in the cell membrane, with one end extending inside the cell and the other wriggling outside. This arrangement allows the protein to gather information outside the cell and send messages to the nucleus, or control center, inside the cell. These messages provide instructions to the cell, including telling it whether or not to grow.
To find out how this process goes awry in people with dwarfism, Hristova is investigating how the mutated protein is embedded within the membrane, compared to the proteins of people who grow normally. Does one type stick farther inside or outside the cell? She also is trying to determine whether the growth disorder is related to the chemical and mechanical ways that the mutated proteins “talk” to other proteins in the cell membrane.
To conduct these studies, Hristova and her team coax cells into making the protein, then “trick” the cells into giving up their membranes with the proteins still embedded in the material. The researchers then use a confocal microscope to gather information about the mutated proteins in these membrane segments without the constant turnover of molecules that occurs in an intact living cell. Her team also works with National Institute of Standards and Technology scientists in using a technology called neutron diffraction to collect images that show where the proteins are situated with respect to the membrane’s surface.
“We are using materials science techniques to conduct innovative research into why this form of dwarfism is occurring,” Hristova said.
Hristova, whose parents are scientists, said that her entry into the field of membrane biophysics occurred “sort of by chance.” In her native Bulgaria, while earning her undergraduate and master’s degrees in physics, she became interested in biophysics. At one point, an instructor assigned her work on membranes, and she quickly embraced this area of research.
She came to the United States to pursue a doctorate in engineering and materials science at Duke, and then further honed her research skills as a postdoctoral fellow at UC Irvine. In 2001, she joined the faculty of the Whiting School of Engineering at Johns Hopkins, where she specializes in membrane biophysics and biomolecular materials and is an affiliate of the Institute for NanoBioTechnology. In 2007, Hristova received the Biophysical Society’s Margaret Oakley Dayhoff award for “her extraordinary and outstanding scientific achievements in biophysics research.”
Her interest in the dwarfism mutation originated years ago when a physician talked to her about the problem and sparked her interest in finding a solution through engineering techniques. In recent years, she has presented her findings at scientific conferences attended mainly by researchers who continue to study the disorder with the tools of a biologist.
“Eventually, sometime in the future, both approaches will come together as we work toward a basic understanding of what causes achondroplasia,” Hristova said. “Then someone will come up with a treatment.”
Photos of Kalina Hristova and her lab team available; contact Phil Sneiderman.Related websites:
Johns Hopkins Institute for NanoBioTechnology: http://inbt.jhu.edu/
Phil Sneiderman | Newswise Science News
An innovative high-performance material: biofibers made from green lacewing silk
20.01.2017 | Fraunhofer-Institut für Angewandte Polymerforschung IAP
Treated carbon pulls radioactive elements from water
20.01.2017 | Rice University
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences